Skip to content
DataLookout
Menu

ADYNCT06913075

FET in Adenomyosis

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 1 year 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below.

  1. Notable Primary completion pushed from Jul 15, 2026 to Sep 15, 2027 Show 4 more changesShow less
    • Start date: Jun 25, 2026 to Jan 16, 2027
    • Study completion pushed from Dec 23, 2026 to Dec 23, 2027
    • Secondary endpoints: details revised at 4 of 6 entries
    • Publications: details revised at 5 of 5 entries
  2. Notable Primary completion date: Jul 15, 2025 to Jul 15, 2026
    • Start date: Jun 25, 2025 to Jun 25, 2026
    • Study completion date: Jan 23, 2026 to Dec 23, 2026
    • Publications: details revised at 5 of 5 entries
    v4
  3. Notable Start date: Apr 25, 2025 to Jun 25, 2025v3
  4. Minor Site contact updatedv2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Ongoing pregnancy rate
Timeframe: 12 weeks of gestation

Secondary (6)

Implantation Rate
Chemical Pregnancy rate
Biochemical loss rate
1st trimester loss
2nd trimester loss
Show 1 moreShow less
Live Birth Rate

Arms and interventions

Group AActive comparator
Group BActive comparator

Drugs: GnRH agonist downregulation, GnRH agonist and Letrozole

Sites

1 site in 1 country

  • Indira IVF Pvt HospitalUdaipur, Rajasthan, India